• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Japan Structural Heart Devices Market

    ID: MRFR/HC/55137-HCR
    200 Pages
    Garvit Vyas
    October 2025

    Japan Structural Heart Devices Market Research Report: By Type (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Structural Heart Devices Market Infographic
    Purchase Options

    Japan Structural Heart Devices Market Summary

    The Japan Structural Heart Devices market is projected to grow significantly from 44.4 million USD in 2024 to 109 million USD by 2035.

    Key Market Trends & Highlights

    Japan Structural Heart Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 8.51 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 109 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 44.4 million USD, reflecting the current demand for structural heart devices in Japan.
    • Growing adoption of innovative technologies due to an increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 44.4 (USD Million)
    2035 Market Size 109 (USD Million)
    CAGR (2025-2035) 8.51%

    Major Players

    Medtronic, Nippon Kayaku, Terumo, AtriCure, Janssen Pharmaceuticals, Cardiac Dimensions, Getinge, Boston Scientific, Abbott, Novartis, Toshiba, LivaNova, Stereotaxis, Edwards Lifesciences, Johnson & Johnson

    Japan Structural Heart Devices Market Trends

    The Japan Structural Heart Devices Market is experiencing notable trends driven primarily by an aging population and rising incidences of cardiovascular diseases in the country. The Japanese government has been proactive in promoting healthcare initiatives and funding for medical technologies that address heart conditions, which is a significant market driver. This focus on improving healthcare infrastructure supports the ongoing development and acceptance of innovative structural heart devices. 

    Additionally, heightened awareness regarding heart health among the Japanese population has increased the demand for effective treatment options. Recent trends highlight the growth of minimally invasive procedures for heart ailments, as they offer quicker recovery times and reduced risks for patients.This shift towards less invasive options is particularly relevant in Japan's healthcare landscape, where there is a strong emphasis on patient safety and comfort. 

    Technological advancements in device design, such as improved implantable devices and the use of biocompatible materials, are also key factors shaping the market. Opportunities abound in the Japanese market as manufacturers look to expand their product offerings to encompass more advanced and varied options for patients.

    Collaborative research efforts between local medical institutions and device manufacturers provide avenues for developing tailored solutions that meet the specific needs of the Japanese population.Overall, the ongoing commitment to healthcare innovation and improvements in treatment practices positions Japan as a fertile ground for the growth of structural heart devices, driving the market forward in the coming years.

    Market Segment Insights

    Structural Heart Devices Market Type Insights

    The Japan Structural Heart Devices Market, particularly categorized by its Type, has shown a diverse range of products catering to various cardiovascular conditions. Heart Valve Devices hold a significant position in the market, primarily due to the increasing prevalence of heart diseases and the aging population in Japan. As Japan has one of the highest life expectancies worldwide, the demand for effective heart valve replacements and repairs is critical, given that these devices can enhance the quality of life for patients suffering from valvular heart diseases.

    Annuloplasty Rings are integral in the structural heart segment as they offer a necessary solution for mitral and tricuspid valve repair by ensuring optimal valve function post-surgery. The minimally invasive nature of these rings helps reduce recovery time, which is appealing in today's healthcare landscape focused on patient outcomes and cost reduction. 

    Occluders have been gaining traction as they prevent blood from flowing into the left atrium in patients with atrial septal defectshus reducing the risk of strokethis aspect is particularly vital given the rising incidence of such ailments in the elderly population.Delivery Systems are essential for the effective deployment of structural heart devices, ensuring that the procedures can be performed with minimal risk and high precision. 

    Their development reflects the ongoing advancements in technology, allowing for improved access during catheter-based procedures. Collectively, these categories illustrate a robust landscape for innovation, with many opportunities for growth driven by changing demographics and technological advancements in Japan's healthcare sector, aiming to better address the rising demands for structural heart interventions.Each Type segment serves a crucial role within the overarching scope of the Japan Structural Heart Devices Market, as they contribute not only to device efficacy but also to improved surgical safety and patient satisfaction.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Structural Heart Devices Market Indication Insights

    The Japan Structural Heart Devices Market, particularly in the indication segment, exhibits promising growth propelled by the rising prevalence of cardiovascular diseases, including Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease is significant due to its impact on morbidity and mortality in Japan, where increasing aging population trends contribute to a higher incidence of this condition. Innovative treatment options and advancements in minimally invasive procedures are enhancing patient outcomes. 

    Similarly, Cardiomyopathy is a critical area, as it affects a substantial number of individuals, leading to heart failure and necessitating early intervention.The growing emphasis on early diagnosis and effective management strategies enhances the demand for advanced structural heart devices. Furthermore, the Japanese government supports healthcare initiatives aimed at addressing cardiovascular health challenges, creating an environment conducive to market expansion. Overall, these indications reflect a shifting focus in the Japan Structural Heart Devices Market, emphasizing innovation and improved patient care to meet the complex needs of this population.

    Structural Heart Devices Market Procedure Insights

    The Japan Structural Heart Devices Market is experiencing notable developments, particularly in the Procedure segment, which encompasses various critical interventions within cardiovascular healthcare. Replacement Procedures and Repair Procedures are pivotal in enhancing patient outcomes for those with structural heart diseases. Replacement Procedures typically involve the implantation of devices such as heart valves, which are essential for restoring proper heart function, especially in an aging population where the incidence of heart-related issues is rising.

    On the other hand, Repair Procedures focus on correcting malformations or damages in the heart structures, thereby preventing further complications and improving the quality of life. The technological advancements in minimally invasive techniques are driving growth in this segment, providing patients with safer and less painful options compared to traditional surgery.

    The growing prevalence of heart diseases in Japan, coupled with increased awareness and early diagnosis, creates substantial growth opportunities for the Procedure segment in the Japan Structural Heart Devices Market.Moreover, the support from government health initiatives and a well-established healthcare infrastructure further solidifies the importance of these procedures in treating structural heart conditions effectively.

    Get more detailed insights about Japan Structural Heart Devices Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    In the Japan Structural Heart Devices Market, the competitive landscape is characterized by a mix of established players and emerging companies striving to innovate and enhance their product offerings. This market segment has seen significant interest due to the rising prevalence of structural heart diseases, which necessitate advanced medical interventions. 

    Companies in this market focus on developing sophisticated devices that cater to a diverse range of conditions, such as atrial septal defects, patent foramen ovale, and valve disorders. The competitive dynamics involve not only traditional competition but also collaborations and partnerships aimed at leveraging technological advancements and improving patient outcomes. Regulatory compliance and a deep understanding of local healthcare frameworks play crucial roles in the strategies adopted by these market participants. Medtronic holds a strong position in the Japan Structural Heart Devices Market, owing to its extensive range of innovative products and substantial investment in research and development. 

    The company's commitment to improving cardiovascular health has led it to introduce various cutting-edge devices tailored to the unique needs of the Japanese population. Medtronic's strengths lie in its robust distribution network, strong relationships with healthcare providers, and ongoing clinical trials that enhance its product credibility. The company has strategically expanded its presence in the Japanese market through targeted efforts to address local healthcare challenges. 

    Medtronic also actively engages in educational initiatives for healthcare professionals to promote awareness and understanding of its structural heart device offerings, further solidifying its dominant position in this specialized market.Nippon Kayaku has made notable strides in the Japan Structural Heart Devices Market, recognized for its innovative medical solutions and diverse portfolio of key products. The company focuses on developing advanced cardiac devices specifically designed for the local market, catering to various heart conditions with precision-engineered solutions. 

    Nippon Kayaku's market presence is bolstered by its strong relationships with healthcare institutions and continuous investment in research that allows for the introduction of innovative technologies tailored the Japanese healthcare system. The company's strengths are derived from its commitment to quality, extensive clinical data supporting its products, and ongoing engagement in collaborations that aim to enhance the efficacy and accessibility of its devices. Additionally, Nippon Kayaku has explored strategic partnerships and potential mergers to amplify its reach and capabilities within the market, thus positioning itself as a formidable player in the structural heart devices sector in Japan.

    Key Companies in the Japan Structural Heart Devices Market market include

    Industry Developments

    The Japan Structural Heart Devices Market has recently seen significant developments. Notably, in August 2023, Medtronic announced the launch of its new heart valve therapy system specifically tailored for the Japanese market, aiming to address the rising prevalence of structural heart diseases. Meanwhile, in July 2023, Terumo launched a cutting-edge catheter that enhances precision in treating heart conditions, reflecting the increasing focus on technological innovation. 

    There have also been discussions around mergers, as Boston Scientific and AtriCure have shown interest in potential collaborations to strengthen their offerings in cardiac therapies. In the valuation landscape, the market has grown steadily, with a reported increase of 5.7% in market size from January 2022 to January 2023, influenced by the aging population in Japan and rising healthcare expenditures. Furthermore, Johnson and Johnson's acquisition of a smaller venture focused on heart pump technology in September 2022 has been a pivotal move, boosting their presence in the market.

    Recent trends indicate a shifting focus toward minimally invasive procedures, which align with the larger global movement in the medical device sector. The Japan Structural Heart Devices Market is adapting rapidly to these evolving demands and technological advancements.

    Market Segmentation

    Outlook

    • Replacement Procedures
    • Repair Procedures

    Structural Heart Devices Market Type Outlook

    • Heart Valve Devices
    • Annuloplasty Rings
    • Occluders
    • Delivery Systems

    Structural Heart Devices Market Procedure Outlook

    • Replacement Procedures
    • Repair Procedures

    Structural Heart Devices Market Indication Outlook

    • Valvular Heart Disease
    • Cardiomyopathy

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 44.38(USD Million)
    MARKET SIZE 2024 48.12(USD Million)
    MARKET SIZE 2035 109.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.715% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Medtronic, Nippon Kayaku, Terumo, AtriCure, Janssen Pharmaceuticals, Cardiac Dimensions, Getinge, Boston Scientific, Abbott, Novartis, Toshiba, LivaNova, Stereotaxis, Edwards Lifesciences, Johnson & Johnson
    SEGMENTS COVERED Type, Indication, Procedure
    KEY MARKET OPPORTUNITIES Aging population driving demand, Innovative minimally invasive procedures, Growth in congenital heart disease cases, Advancements in biocompatible materials, Increased healthcare expenditure for cardiovascular health
    KEY MARKET DYNAMICS aging population, increasing cardiovascular diseases, technological advancements, favorable reimbursement policies, rising healthcare expenditure
    COUNTRIES COVERED Japan

    FAQs

    What is the expected market size of the Japan Structural Heart Devices Market in 2024?

    The Japan Structural Heart Devices Market is expected to be valued at 48.12 million USD in 2024.

    What will be the projected market value of the Japan Structural Heart Devices Market in 2035?

    By 2035, the Japan Structural Heart Devices Market is projected to reach a value of 109.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the Japan Structural Heart Devices Market from 2025 to 2035?

    The expected CAGR for the Japan Structural Heart Devices Market from 2025 to 2035 is 7.715%.

    Which type of structural heart device is expected to have the highest market value in 2035?

    Heart Valve Devices are expected to have the highest market value, projected at 45.0 million USD in 2035.

    What market value is anticipated for Occluders in the Japan Structural Heart Devices Market in 2024?

    Occluders are anticipated to have a market value of 10.8 million USD in 2024.

    Who are the major players in the Japan Structural Heart Devices Market?

    Major players in the market include Medtronic, Terumo, Boston Scientific, and Abbott.

    What is the expected market size for Annuloplasty Rings in 2035?

    The expected market size for Annuloplasty Rings in 2035 is projected to be 21.0 million USD.

    What are the projected market values for Delivery Systems in 2024 and 2035?

    Delivery Systems are projected to have values of 8.52 million USD in 2024 and 18.5 million USD in 2035.

    What are the key growth drivers in the Japan Structural Heart Devices Market?

    Key growth drivers include increasing prevalence of heart diseases and advancements in medical technology.

    How will the Japan Structural Heart Devices Market perform in the coming years?

    The market is expected to witness steady growth fueled by innovation and rising healthcare expenditure.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials